van Swinderen B, Shook D R, Ebert R H, Cherkasova V A, Johnson T E, Shmookler Reis R J, Crowder C M
Department of Anesthesiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):8232-7. doi: 10.1073/pnas.94.15.8232.
Genetic analysis is an essential tool for defining the molecular mechanisms whereby volatile anesthetics (VA) disrupt nervous system function. However, the degree of natural variation of the genetic determinants of VA sensitivity has not been determined nor have mutagenesis approaches been very successful at isolating significantly resistant mutant strains. Thus, a quantitative genetic approach was taken toward these goals. Recombinant-inbred strains derived from two evolutionarily distinct lineages of the nematode Caenorhabditis elegans were tested for sensitivity to clinically relevant concentrations (0.3-0.5 mM) of the VA halothane. The halothane sensitivities of coordinated movement and male mating behavior were highly variant among the recombinant-inbred strains with a range of EC50 values of 13- and 4-fold, respectively. Both traits were highly heritable (H2 = 0.82, 0.87, respectively). Several strains were found to be significantly resistant to halothane when compared with the wild-type strain N2. A major locus or loci mapping to the middle of chromosome V accounted for more than 40% of the phenotypic variance for both traits. Five weaker loci, four of which interact, explained most of the remaining variance. None of the halothane-sensitivity quantitative trait loci significantly affected behavior in the absence of halothane or halothane's potency for C. elegans immobilization, which requires 5-fold higher drug concentrations. Thus, the quantitative trait loci are unlikely to result from differences in halothane-independent (native) behavior or differences in halothane metabolism or permeability. Rather, these loci may code for targets and/or downstream effectors of halothane in the C. elegans nervous system or for modifiers of such gene products.
基因分析是确定挥发性麻醉剂(VA)破坏神经系统功能分子机制的重要工具。然而,VA敏感性遗传决定因素的自然变异程度尚未确定,诱变方法在分离出显著抗性突变菌株方面也不太成功。因此,针对这些目标采用了定量遗传学方法。对线虫秀丽隐杆线虫两个进化上不同谱系的重组自交系进行了测试,以检测其对临床相关浓度(0.3 - 0.5 mM)的VA氟烷的敏感性。在重组自交系中,协调运动和雄性交配行为的氟烷敏感性差异很大,EC50值范围分别为13倍和4倍。这两个性状都具有高度遗传性(H2分别为0.82和0.87)。与野生型菌株N2相比,发现有几个菌株对氟烷具有显著抗性。一个或多个主要基因座定位于第五条染色体的中部,占这两个性状表型变异的40%以上。另外五个较弱的基因座,其中四个相互作用,解释了其余大部分变异。在没有氟烷的情况下,氟烷敏感性数量性状基因座均未显著影响行为,也未影响氟烷使秀丽隐杆线虫固定的效力,后者需要高5倍的药物浓度。因此,数量性状基因座不太可能源于与氟烷无关的(天然)行为差异、氟烷代谢或通透性差异。相反,这些基因座可能编码秀丽隐杆线虫神经系统中氟烷的靶点和/或下游效应器,或此类基因产物的修饰因子。